Advisors Preferred LLC Has $1.17 Million Stake in Humana Inc. $HUM

Advisors Preferred LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 151.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,724 shares of the insurance provider’s stock after buying an additional 2,842 shares during the period. Advisors Preferred LLC’s holdings in Humana were worth $1,166,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Factorial Partners LLC acquired a new stake in shares of Humana during the 3rd quarter valued at about $781,000. Stevens Capital Management LP acquired a new position in Humana in the third quarter worth about $629,000. Raiffeisen Bank International AG lifted its stake in Humana by 4.8% during the third quarter. Raiffeisen Bank International AG now owns 7,132 shares of the insurance provider’s stock worth $1,820,000 after purchasing an additional 324 shares during the period. AMG National Trust Bank boosted its holdings in Humana by 106.5% during the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock valued at $4,411,000 after purchasing an additional 8,744 shares in the last quarter. Finally, Bridgewater Advisors Inc. grew its stake in shares of Humana by 9.1% in the 3rd quarter. Bridgewater Advisors Inc. now owns 1,131 shares of the insurance provider’s stock valued at $284,000 after purchasing an additional 94 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 0.3%

HUM opened at $189.95 on Friday. Humana Inc. has a 1-year low of $169.61 and a 1-year high of $315.35. The stock has a market capitalization of $22.85 billion, a PE ratio of 19.34, a PEG ratio of 2.03 and a beta of 0.44. The company has a current ratio of 2.00, a quick ratio of 2.02 and a debt-to-equity ratio of 0.70. The firm has a 50-day moving average price of $237.44 and a two-hundred day moving average price of $258.76.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. During the same period in the prior year, the business earned ($2.16) earnings per share. Humana’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio is 36.05%.

Wall Street Analyst Weigh In

Several research firms recently commented on HUM. Truist Financial cut their target price on Humana from $285.00 to $200.00 and set a “hold” rating for the company in a research report on Tuesday, February 17th. Barclays reissued an “underperformer” rating on shares of Humana in a report on Monday, January 5th. The Goldman Sachs Group lowered their target price on shares of Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Oppenheimer set a $250.00 target price on shares of Humana in a research report on Thursday, February 12th. Finally, Wolfe Research upped their price objective on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, January 8th. Seven analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $228.48.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.